|
???tair.name??? >
???browser.page.title.author???
|
"su w"???jsp.browse.items-by-author.description???
Showing items 11-21 of 21 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2019-07-22T01:45:09Z |
Defect engineering of metal-oxide interface for proximity of photooxidation and photoreduction
|
Yu G.;Wang X.;Basset J.-M.;Wu J.C.S.;Zhang Y.;Su W.;Tong Y.;Chen L.;Long J.;Ling L.;Qiu M.;Fang Z.;Zhang Z.;Zhou Y.; Zhou Y.; Zhang Z.; Fang Z.; Qiu M.; Ling L.; Long J.; Chen L.; Tong Y.; Su W.; Zhang Y.; Wu J.C.S.; Basset J.-M.; Wang X.; Yu G. |
臺大學術典藏 |
2018-09-10T15:34:41Z |
The effect of biodiversity on green space users' wellbeing-An empirical investigation using physiological evidence
|
Chang, K.G.;Sullivan, W.C.;Lin, Y.-H.;Su, W.;Chang, C.-Y.; Chang, K.G.; Sullivan, W.C.; Lin, Y.-H.; Su, W.; Chang, C.-Y.; CHUN-YEN CHANG |
國立成功大學 |
2015-10 |
Prognostic Significance of Changes of Volumetric Metabolic Parameters in 18F-FDG PET/CT During and After Radiotherapy in Stage III Non-Small Cell Lung Cancer
|
Chiu, N.; Su, W.; Guo, H.; Lee, B.; Chen, H. |
國立成功大學 |
2015-05 |
COMPARISON OF EXPECTED HEALTH IMPACTS FOR MAJOR CANCERS: INTEGRATION OF INCIDENCE RATE AND LOSS OF QUALITY-ADJUSTED LIFE EXPECTANCY
|
Hung, M.; Lai, W.; Chen, H. H.; Su, W.; Wang, J. |
國立成功大學 |
2014-11 |
Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma
|
Lin, C.; Su, W.; Lee, J.; Hsu, C.; Cheng, A.; Lin, C.; Ho, H.; Huang, C.; Hsueh, S.; Yang, J |
國家衛生研究院 |
2012-09 |
Early data from a phase I study of nintedanib (BIBF1120) in Asian patients with advanced hepatocellular carcinoma
|
Yen, C;Shen, Y;Shiah, H;Chen, J;Hsu, C;Huang, DC;Hocke, J;Su, W;Cheng, A |
國家衛生研究院 |
2011-02 |
A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer
|
Ko, AH;Tempero, MA;Shan, Y;Su, W;Lin, Y;Dito, E;Ong, A;Yeh, G;Chen, L |
國家衛生研究院 |
2011-02 |
Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers
|
Yeh, K;Shen, Y;Li, C;Yen, C;Hsu, C;Lin, Z;Chen, L;Su, W;Chao, Y;Cheng, A |
國家衛生研究院 |
2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma
|
Shiah, H;Chen, C;Lin, Y;Su, W;Winkler, R;Chang, J;Lin, P;Whang-Peng, J;Chen, L |
元智大學 |
2004-10 |
電力服務業競價最佳化之研究
|
邱昭彰; Su, W.; Lin, G. |
國立成功大學 |
2004-02-25 |
Growth of ZnSe films on ZnO-Si templates
|
Wang, X. H.; Fan, X. W.; Shan, C. X.; Zhang, Z. Z.; Su, W; Zhang, J. Y.; Su, Yan-Kuin; Chang, Shoou-Jinn; Lu, Y. M.; Liu, Y. C.; Shen, D. Z. |
Showing items 11-21 of 21 (1 Page(s) Totally) 1 View [10|25|50] records per page
|